Also trades as: CSLLY (OTC) · $vol 11M · CMXHF (OTC) · $vol 0M

A$175.91 ($122.31)

-2.33 (-1.31%)

Weekly Expected Move ±3.5%

A$163 A$169 A$175 A$182 A$188

ASX · Healthcare · Biotechnology · Tech Score Buy · Power 59 · A$84.0B mcap · 482M float · 0.330% daily turnover

Revenue

$16.0B +4.0% ▲

5Y CAGR: +9.2%

Gross Profit

$7.7B -3.7% ▼

5Y CAGR: +5.7%

Operating Income

$4.1B +38.5% ▲

5Y CAGR: +9.6%

Net Income

-$2.6B -187.8% ▼

EPS (Diluted)

$-5.47 -188.5% ▼

EBITDA

$5.2B +0.6% ▲

5Y CAGR: +7.3%

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$10.5B	$13.2B	$14.7B	$15.4B	$16.0B
YoY Growth	+1.6%	+25.5%	+11.5%	+5.0%	+4.0%
Cost of Revenue	$4.8B	$6.5B	$7.1B	$7.5B	$8.4B
Gross Profit	$5.7B	$6.7B	$7.6B	$8.0B	$7.7B
Gross Margin	54.0%	50.9%	51.5%	51.5%	47.7%
R&D Expenses	$1.2B	$1.8B	$1.4B	$1.4B	$1.2B
SG&A Expenses	$1.6B	$2.5B	$2.4B	$2.6B	$2.2B
Operating Expenses	$3.3B	$4.6B	$4.8B	$5.0B	$3.6B
Operating Income	$2.3B	$2.1B	$2.8B	$3.0B	$4.1B
Operating Margin	22.1%	16.0%	18.8%	19.2%	25.6%
Interest Expense	$143M	$408M	$420M	$393M	$439M
Income Before Tax	$2.8B	$2.7B	$3.4B	$3.7B	-$4.2B
Tax Expense	$724M	$419M	$661M	$588M	-$1.1B
Net Income	$2.3B	$2.2B	$2.6B	$3.0B	-$2.6B
Net Margin	21.5%	16.7%	18.0%	19.5%	-16.4%
EPS (Diluted)	$4.80	$6.89	$5.45	$6.18	$-5.47
EBITDA	$3.5B	$3.9B	$4.7B	$5.1B	$5.2B
Shares Outstanding	470M	484M	485M	486M	482M

Line Item	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2	FY2026 Q4
Revenue	$7.3B	$5.9B	$8.4B	$6.8B	$8.2B	$7.3B	$8.4B	$7.3B
Cost of Revenue	$3.5B	$3.3B	$4.1B	$3.7B	$3.9B	$3.9B	$4.2B	$4.1B
Gross Profit	$3.8B	$2.6B	$4.3B	$3.1B	$4.3B	$3.4B	$4.3B	$3.2B
Gross Margin	51.6%	44.5%	51.3%	45.5%	52.1%	46.3%	50.7%	44.4%
R&D Expenses	$588M	$647M	$699M	$770M	$646M	$739M	$611M	$614M
SG&A Expenses	$1.0B	$1.2B	$1.3B	$1.2B	$1.2B	$1.4B	$1.0B	$1.1B
Operating Expenses	$1.6B	$1.8B	$1.6B	$1.9B	$2.3B	$2.0B	$1.6B	$1.9B
Operating Income	$2.1B	$816M	$2.7B	$1.1B	$2.0B	$1.4B	$2.6B	$1.4B
Operating Margin	29.4%	13.8%	32.1%	16.9%	24.1%	19.3%	31.3%	19.0%
Interest Expense	$307M	$353M	$389M	$337M	$213M	$216M	$217M	$214M
Income Before Tax	$2.9B	$1.0B	$3.5B	$1.5B	$2.5B	$1.2B	$387M	-$4.4B
Tax Expense	$330M	$94M	$479M	$205M	$484M	$108M	$96M	-$1.2B
Net Income	$2.4B	$894M	$2.9B	$1.1B	$2.0B	$1.0B	$408M	-$2.9B
Net Margin	33.6%	15.1%	34.8%	16.4%	24.4%	14.2%	4.8%	-40.2%
EPS (Diluted)	$3.46	$1.22	$4.09	$2.32	$4.13	$2.12	$0.84	$-6.14
EBITDA	$2.6B	$1.4B	$3.2B	$2.4B	$3.2B	$2.0B	$3.1B	$1.9B
Shares Outstanding	484M	485M	485M	486M	486M	486M	486M	479M

CSL.AX ASX